Article
Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers
17 Apr 2018
Abstract excerpt
Abstract Cell therapy using renal progenitors differentiated from human embryonic stem cells (hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce the number of patients receiving dialysis therapy. However, the differentiation cultures may contain undifferentiated or undesired cell types that cause unwanted side effects, such as neoplastic formation, when transplanted into a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
